R. Martínez

Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery

M. Artola, M. López-Rodríguez, C. Fernández‐Tornero, 2021, Journal of medicinal chemistry.

On the Origin of Sugar Handedness: Facts, Hypotheses and Missing Links-A Review

P. Cintas, L. Cuccia, C. Viedma, 2022, Origins of Life and Evolution of Biospheres.

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Manisha Ray, M. López-Rodríguez, S. Ortega‐Gutiérrez, 2022, Journal of medicinal chemistry.

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.

J. Chun, A. Ferrer-Montiel, R. Rivera, 2019, Journal of medicinal chemistry.

Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.

D. Mayleben, S. Deacon, C. Guico-Pabia, 2008, Sleep medicine.